Susquehanna International Group, LLP Mereo Biopharma Group PLC Call Options Transaction History

Susquehanna International Group, LLP

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$3.45 - $4.87 $341,550 - $482,130	99,000 Added 106.45%	192,000 $789,000
Q2 2024 Aug 15, 2024	SELL	$2.58 - $4.25 $67,338 - $110,925	-26,100 Reduced 21.91%	93,000 $334,000
Q1 2024 May 07, 2024	BUY	$2.3 - $4.05 $166,980 - $294,030	72,600 Added 156.13%	119,100 $393,000
Q4 2023 Feb 14, 2024	SELL	$1.19 - $2.42 $65,807 - $133,826	-55,300 Reduced 54.32%	46,500 $107,000
Q3 2023 Nov 14, 2023	SELL	$1.15 - $1.67 $206,769 - $300,266	-179,800 Reduced 63.85%	101,800 $131,000
Q2 2023 Aug 11, 2023	BUY	$0.79 - $1.43 $196,236 - $355,212	248,400 Added 748.19%	281,600 $371,000
Q1 2023 May 16, 2023	BUY	$0.71 - $1.22 $23,572 - $40,504	33,200 New	33,200 $23,000
Q3 2022 Nov 14, 2022	SELL	$0.82 - $1.73 $19,270 - $40,655	-23,500 Reduced 49.58%	23,900 $21,000
Q2 2022 Aug 15, 2022	BUY	$0.33 - $1.69 $396 - $2,028	1,200 Added 2.6%	47,400 $53,000
Q1 2022 May 16, 2022	BUY	$1.04 - $1.7 $7,384 - $12,070	7,100 Added 18.16%	46,200 $52,000
Q3 2021 Nov 15, 2021	SELL	$2.2 - $3.17 $69,300 - $99,855	-31,500 Reduced 44.62%	39,100 $95,000
Q2 2021 Aug 11, 2021	SELL	$2.94 - $4.08 $5,880 - $8,160	-2,000 Reduced 2.75%	70,600 $224,000
Q1 2021 May 17, 2021	BUY	$2.6 - $4.43 $188,760 - $321,618	72,600 New	72,600 $245,000

107M

209K

479K

Ticker MREO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,986,000
Market Cap $425M
Description
Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.